cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Nrx Pharmaceuticals Inc
13 own
16 watching
Current Price
$5.06
$0.15
(3.05%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
17.32M
52-Week High
52-Week High
7.33000
52-Week Low
52-Week Low
1.10000
Average Volume
Average Volume
4.29M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization17.32M
icon52-Week High7.33000
icon52-Week Low1.10000
iconAverage Volume4.29M
iconDividend Yield--
iconP/E Ratio--
What does the Nrx Pharmaceuticals Inc do?
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. The Company is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 is a combined NMDA/5-HT2A-targeted medicine designed to address both depression and suicidal ideation, consisting of an oral, fixed dose combination of DCS and lurasidone. Its NRX-100 is racemic ketamine, which is a generic anesthetic. The Company is also engaged in the development of its new product, NRX-102.
Read More
How much money does Nrx Pharmaceuticals Inc make?
News & Events about Nrx Pharmaceuticals Inc.
Globe Newswire
1 year ago
NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased NRx Pharmaceuticals Inc. (f/k/a Big Rock Partners Acquisition Corp.) ("NRXP" or the "Company") (NASDAQ:NRXP) stockprior toMay 24, 2021and still hold...
PR Newswire
1 year ago
NRXP ALERT: Levi & Korsinsky, LLP Announces an Investigation into the Fairness of NRx Pharmaceuticals Inc.'s De-SPAC Merger NRXP ALERT: Levi & Korsinsky, LLP Announces an Investigation into the Fairness of NRx Pharmaceuticals Inc.'s De-SPAC Merger PR Newswire NEW YORK, June 15, 2023...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of NRx Pharmaceuticals, Inc. and Encourages Long-Term NRXP / BRPA Shareholders to Contact the Firm SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of NRx Pharmaceuticals, Inc. and Encourages Long-Term NRXP / BRPA Shareholders to...
PR Newswire
1 year ago
NRx Pharmaceuticals Announces Closing of $6.28 Million Registered Direct Offering NRx Pharmaceuticals Announces Closing of $6.28 Million Registered Direct Offering PR Newswire RADNOR, Pa., June 9, 2023 RADNOR, Pa., June 9, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ('NRx...
PR Newswire
1 year ago
NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 PR Newswire RADNOR, Pa., March 17, 2023 RADNOR, Pa., March 17, 2023 /PRNewswire/ -- NRx...
Frequently Asked Questions
Frequently Asked Questions
What is Nrx Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Nrx Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Nrx Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Nrx Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Nrx Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Nrx Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Nrx Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Nrx Pharmaceuticals Inc?
plus_minus_icon
What percentage is Nrx Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Nrx Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.06
$0.15
(3.05%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00